SPACA6 and breast cancer: Within the scope of this investigation, through analysis of RNA sequencing and clinical data from 1083 BC patients in the TCGA database, we confirmed a significant upregulation of SPACA6P-AS in BC tissues, closely correlated with unfavorable outcome.